More tools:Markets·Screener·Research·Chat

Journey Medical Corporation Common Stock (DERM) Financial Statements

Journey Medical Corporation Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00ZWVDRL1
XNAS · usd
7.81▼ 0.16 (-2.03%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close7.97
Day's Range7.67 – 7.98
52-Week Range4.31 – 9.56
Volume134.1K
Avg Volume189.1K
Share Statistics
Shares Outstanding
Employees—
ExchangeXNAS
Listed2021-11-12
Share count as of August 11, 2026
Loading Income Statement…
Key questions about Journey Medical Corporation Common Stock (DERM)
What is Journey Medical Corporation Common Stock's Market Cap?
Journey Medical Corporation Common Stock's Market Cap is $220.4M, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's Enterprise Value?
Journey Medical Corporation Common Stock's Enterprise Value is $220.2M, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's Price / Sales?
Journey Medical Corporation Common Stock's Price / Sales is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's EV / Revenue?
Journey Medical Corporation Common Stock's EV / Revenue is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's EV / EBITDA?
Journey Medical Corporation Common Stock's EV / EBITDA is 330.5×, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's Revenue (TTM)?
Journey Medical Corporation Common Stock's Revenue (TTM) is $66.9M, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's Net Income (TTM)?
Journey Medical Corporation Common Stock's Net Income (TTM) is -$6.1M, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's EBITDA?
Journey Medical Corporation Common Stock's EBITDA is $1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's Diluted EPS (TTM)?
Journey Medical Corporation Common Stock's Diluted EPS (TTM) is -0.22, based on as-reported figures from SEC (XBRL) filings.
What is Journey Medical Corporation Common Stock's EBITDA Margin?
Journey Medical Corporation Common Stock's EBITDA Margin is 1.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Product revenue, net
YoY growth+18.9%+21.2%+27.3%+16.4%
Other revenue
Total revenue
Operating expenses
Cost of goods sold - (excluding amortization of acquired intangible assets)
Amortization of acquired intangible assets
Research and development—
Selling, general and administrative
Total operating expenses
% of revenue101.2%109.6%102.8%112.5%
Income (loss) from operations
% of revenue2.6%-9.4%-2.8%-9.0%
Other expense (income)
Interest income
Interest expense
Foreign exchange transaction losses
Total other expense
Loss before income taxes
Income tax expense—
Net loss
% of revenue-1.7%-14.0%-7.8%-13.6%
Basic (In dollars per share)
Diluted (In dollars per share)